Conestoga Capital Advisors, an asset management company, released its second-quarter 2025 investor letter. A copy of the ...

Veeva Systems (VEEV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review ...

Veeva Systems reported fiscal first-quarter results Wednesday that beat expectations, but weren't too exciting. The stock soared in response to management's outlook, which implies stronger growth ...

VEEV stock climbs 36% YTD as it accelerates its shift off Salesforce, betting on Vault to power future growth in life sciences.

Buying $100 In VEEV: If an investor had bought $100 of VEEV stock 10 years ago, it would be worth $1,074.72 today based on a price of $292.60 for VEEV at the time of writing.

Veeva Systems also added 13 new Vault CRM customers in the fiscal third quarter. In September, VEEV commented on the release of Veeva Site Connect, which is part of the Veeva Clinical Platform.

Veeva Systems (NYSE: VEEV) has nearly tripled revenues and earnings over the past five years, but the stock's getting beaten down so badly that investors are starting to wonder if it's still a ...

Life sciences CRM provider Veeva Systems this afternoon reported fiscal Q4 revenue and profit that topped analysts' expectations, and an outlook that for this quarter's revenue and profit higher ...

Summary. Veeva Systems is a cloud-based software solution provider for the pharmaceutical and life sciences industries. Veeva is valued at over $20 billion and is considered a top player in the ...

Shares of Veeva Systems (VEEV-1.17%) leapt about 6% on Thursday, March 2, following a fiscal-fourth-quarter earnings report that management announced the previous afternoon.

Veeva Systems is witnessing a positive estimate revision trend for fiscal 2025. In the past 60 days, the Zacks Consensus Estimate for fiscal 2025 earnings per share (EPS) has moved 22 cents north ...